Mavacoxib (CAS 170569-88-7) is an advanced veterinary non-steroidal anti-inflammatory drug (NSAID) manufactured under strict in-house quality standards to ensure reliable purity, consistency, and safety. As a highly selective COX-2 inhibitor , it effectively targets inflammation and pain while sparing COX-1 - an essential enzyme that protects the gastrointestinal tract and renal system. This selectivity provides powerful therapeutic benefits with a lower risk of adverse effects, making Mavacoxib a trusted API in modern veterinary medicine.

What is Mavacoxib?

Mavacoxib is a long-acting NSAID developed specifically for veterinary use, especially in dogs suffering from chronic pain and inflammatory diseases . By selectively inhibiting the COX-2 enzyme, it reduces inflammation at the source while maintaining COX-1 function, helping minimize common NSAID-related side effects such as gastric ulceration or kidney irritation.

This pharmacological profile makes Mavacoxib an ideal candidate for formulating safe, effective, and long-duration treatments.

Key Applications in Veterinary Care

✔ Osteoarthritis (Primary Use)

Mavacoxib is widely prescribed for canine osteoarthritis , a degenerative joint condition that leads to:

• Joint stiffness
• Chronic pain
• Reduced mobility
• Decreased quality of life

Its long-lasting activity is especially beneficial for senior dogs and breeds prone to joint disorders.

✔ Soft Tissue Injuries

• Reduces swelling
• Alleviates pain
• Supports functional recovery

✔ Post-operative Pain Management

Used after orthopedic, soft tissue, or dental procedures to control pain and inflammation. Its extended action reduces the need for repeated dosing.

✔ Dental Pain

Effective for managing discomfort associated with periodontal disease or dental extractions.

Advantages of Mavacoxib

• ✔ Long-Lasting Action – Convenient dosing and consistent outcomes
• ✔ COX-2 Selectivity – Lower risk of GI and renal side effects
• ✔ High Treatment Compliance – Ideal for chronic therapy
• ✔ Safe and Effective – Reliable relief under veterinary supervision

Responsible Use & Veterinary Guidance

Mavacoxib should always be administered under veterinary supervision. Dosage depends on:

• Dog's age
• Weight
• Severity of condition
• Overall health status

About the Manufacturer

Xiamen Origin Biotech Co., Ltd , located in the Xiamen Torch Hi-tech Industrial Development Zone , is a State Hi-tech Enterprise specializing in hormones, proteins & peptides, prostaglandins, small molecular compounds, and human and veterinary pharmaceutical APIs. The company integrates R&D, manufacturing, and global sales to meet international standards.

FAQs

Q: Can packaging be customized?

A: Yes. We offer various packaging options including glass bottles and foil bags, in both small divided packages and bulk quantities.

Q: How are products delivered?

A: We ship via express (eg, FedEx) or air transport based on customer requirements.

Conclusion

Mavacoxib (CAS 170569-88-7) is a highly effective, long-acting, and safer option for managing chronic pain and inflammation in dogs. Its COX-2 selective mechanism provides powerful relief with fewer side effects, while its convenient dosing schedule enhances treatment compliance. As part of comprehensive veterinary care, Mavacoxib improves mobility, comfort, and overall quality of life.